252 related articles for article (PubMed ID: 22570727)
1. Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
Park JE; Son AI; Hua R; Wang L; Zhang X; Zhou R
PLoS One; 2012; 7(5):e36564. PubMed ID: 22570727
[TBL] [Abstract][Full Text] [Related]
2. A Novel Human Congenital Cataract Mutation in EPHA2 Kinase Domain (p.G668D) Alters Receptor Stability and Function.
Zhai Y; Zhu S; Li J; Yao K
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4717-4726. PubMed ID: 31725171
[TBL] [Abstract][Full Text] [Related]
3. Diverse roles of Eph/ephrin signaling in the mouse lens.
Cheng C; Gong X
PLoS One; 2011; 6(11):e28147. PubMed ID: 22140528
[TBL] [Abstract][Full Text] [Related]
4. Structural investigation of a C-terminal EphA2 receptor mutant: Does mutation affect the structure and interaction properties of the Sam domain?
Mercurio FA; Costantini S; Di Natale C; Pirone L; Guariniello S; Scognamiglio PL; Marasco D; Pedone EM; Leone M
Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1095-1104. PubMed ID: 28602916
[TBL] [Abstract][Full Text] [Related]
5. EphA2 and ephrin-A5 are not a receptor-ligand pair in the ocular lens.
Cheng C; Fowler VM; Gong X
Exp Eye Res; 2017 Sep; 162():9-17. PubMed ID: 28648759
[TBL] [Abstract][Full Text] [Related]
6. EPHA2 MUTATIONS CONTRIBUTE TO CONGENITAL CATARACT THROUGH DIVERSE MECHANISMS.
Dave A; Martin S; Kumar R; Craig JE; Burdon KP; Sharma S
Mol Vis; 2016; 22():18-30. PubMed ID: 26900323
[TBL] [Abstract][Full Text] [Related]
7. The SAM domain inhibits EphA2 interactions in the plasma membrane.
Singh DR; Ahmed F; Paul MD; Gedam M; Pasquale EB; Hristova K
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):31-38. PubMed ID: 27776928
[TBL] [Abstract][Full Text] [Related]
8. EPHA2 is associated with age-related cortical cataract in mice and humans.
Jun G; Guo H; Klein BE; Klein R; Wang JJ; Mitchell P; Miao H; Lee KE; Joshi T; Buck M; Chugha P; Bardenstein D; Klein AP; Bailey-Wilson JE; Gong X; Spector TD; Andrew T; Hammond CJ; Elston RC; Iyengar SK; Wang B
PLoS Genet; 2009 Jul; 5(7):e1000584. PubMed ID: 19649315
[TBL] [Abstract][Full Text] [Related]
9. Further analysis of the lens of ephrin-A5-/- mice: development of postnatal defects.
Son AI; Cooper MA; Sheleg M; Sun Y; Kleiman NJ; Zhou R
Mol Vis; 2013; 19():254-66. PubMed ID: 23401654
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of deleterious
Li D; Han X; Zhao Z; Lu Y; Yang J
Mol Vis; 2021; 27():403-414. PubMed ID: 34267496
[TBL] [Abstract][Full Text] [Related]
11. Binding and function of phosphotyrosines of the Ephrin A2 (EphA2) receptor using synthetic sterile α motif (SAM) domains.
Borthakur S; Lee H; Kim S; Wang BC; Buck M
J Biol Chem; 2014 Jul; 289(28):19694-703. PubMed ID: 24825902
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.
Fang WB; Brantley-Sieders DM; Hwang Y; Ham AJ; Chen J
J Biol Chem; 2008 Jun; 283(23):16017-26. PubMed ID: 18387945
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of deleterious
Li D; Han X; Zhao Z; Lu Y; Yang J
Mol Vis; 2021; 27():384-395. PubMed ID: 34220184
[TBL] [Abstract][Full Text] [Related]
14. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.
Miao H; Li DQ; Mukherjee A; Guo H; Petty A; Cutter J; Basilion JP; Sedor J; Wu J; Danielpour D; Sloan AE; Cohen ML; Wang B
Cancer Cell; 2009 Jul; 16(1):9-20. PubMed ID: 19573808
[TBL] [Abstract][Full Text] [Related]
15. EphA2 Receptor Unliganded Dimers Suppress EphA2 Pro-tumorigenic Signaling.
Singh DR; Ahmed F; King C; Gupta N; Salotto M; Pasquale EB; Hristova K
J Biol Chem; 2015 Nov; 290(45):27271-27279. PubMed ID: 26363067
[TBL] [Abstract][Full Text] [Related]
16. Epha2 and Efna5 participate in lens cell pattern-formation.
Zhou Y; Shiels A
Differentiation; 2018; 102():1-9. PubMed ID: 29800803
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells.
Yang NY; Fernandez C; Richter M; Xiao Z; Valencia F; Tice DA; Pasquale EB
Cell Signal; 2011 Jan; 23(1):201-12. PubMed ID: 20837138
[TBL] [Abstract][Full Text] [Related]
18. Mapping the Universe of Eph Receptor and Ephrin Ligand Transcripts in Epithelial and Fiber Cells of the Eye Lens.
Vu MP; Cheng C
Cells; 2022 Oct; 11(20):. PubMed ID: 36291158
[TBL] [Abstract][Full Text] [Related]
19. Point mutations in dimerization motifs of the transmembrane domain stabilize active or inactive state of the EphA2 receptor tyrosine kinase.
Sharonov GV; Bocharov EV; Kolosov PM; Astapova MV; Arseniev AS; Feofanov AV
J Biol Chem; 2014 May; 289(21):14955-64. PubMed ID: 24733396
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract.
Zhang T; Hua R; Xiao W; Burdon KP; Bhattacharya SS; Craig JE; Shang D; Zhao X; Mackey DA; Moore AT; Luo Y; Zhang J; Zhang X
Hum Mutat; 2009 May; 30(5):E603-11. PubMed ID: 19306328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
